Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 50-70 years 2. Patients of either sex 3. Diagnosed knee OA as per American College of Rheumatology (ACR) clinical/radiographic classification criteria: a) Knee pain b) At least 1 of 3: age more than 50 years, stiffness less than 30 min, and crepitus on knee motion c) Osteophytes on knee x-ray 4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of OA, provided the medications are stopped completely at least 2 weeks prior study entry 5. Literate patients; can read Bengali or English 6. Providing written informed consent
Exclusion criteria
Exclusion criteria: 1. Severe degeneration of knee joint with marked joint narrowing, varus, or valgus deformity of knee ( >12°), evidenced by imaging or other evidences and requiring surgical intervention 2. Non-ambulant patients 3. Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricaemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) 4. Intra-articular injections within 2 weeks before study entry 5. Transplanted knees 6. Recent significant knee surgery within last 6 months 7. Patients who are too sick for consultation 8. Unwilling to take part and not giving consent to join the study 9. Unable to read patient information sheet 10. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 11. Pregnancy, puerperium and lactation 12. Substance abuse and/or dependence 13. Self-reported immune-compromised state, and 14. Undergoing homoeopathic treatment for any chronic disease within last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knee injury and osteoarthritis outcome scores (KOOS)Timepoint: At baseline and every month up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of add-on paracetamol and/or NSAIDs (oral/topical) during study periodTimepoint: At baseline and every month up to 3 months;Measure yourself medical outcome profile version-2 (MYMOP-2)Timepoint: At baseline and every month up to 3 months | — |
Countries
India
Contacts
D. N. De Homoeopathic Medical College and Hospital